Apotex pays Texas $ 26 million to end Medicaid fraud investigation


Law360 (July 16, 2021, 6:54 p.m. EDT) – Pharmaceutical maker Apotex Corp. agreed in an out-of-court settlement to pay the state of Texas $ 26 million to resolve allegations it reported inflated drug prices to Medicaid in Texas. program for more than three decades, the Texas attorney general said Friday.

Texas contends, and Apotex denies, that since Jan. 1, 1991, it has falsely reported inflated drug prices to the Texas Medicaid program, thereby increasing the reimbursement it has obtained from the state, in violation of Texas Medicaid Fraud Prevention. Act.

Among the dozens of drugs that Texas claimed Apotex mispriced were the potent opioid fentanyl, nicotine patches …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific articles and topics and more!


Source link

Leave A Reply

Your email address will not be published.